CHEMOMAB THERAPEUTICS LTD (CMMB) Stock Balance Sheet
NASDAQ:CMMB • US16385C2035
1.64 USD
+0.13 (+8.61%)
At close: Feb 19, 2026
1.62 USD
-0.02 (-1.22%)
After Hours: 2/19/2026, 8:00:01 PM
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 6.97M | 6.07M | 9.29M | 13.52M | 15.19M | |||
| Marketable Securities | 3.08M | 8.20M | 10.49M | 26.37M | 45.98M | |||
| Other Current Assets | 1.87M | 1.77M | 1.11M | 1.85M | 1.53M | |||
| Total Current Assets | 11.93M | 16.04M | 20.90M | 41.74M | 62.69M | |||
| Non-Current Assets | ||||||||
| PPE Net | 188.00K | 539.00K | 695.00K | 590.00K | 700.00K | |||
| Other Non-Current Assets | 254.00K | 385.00K | 559.00K | 730.00K | 960.00K | |||
| Total Non-Current Assets | 442.00K | 924.00K | 1.25M | 1.32M | 1.66M | |||
| TOTAL ASSETS | 12.37M | 16.96M | 22.15M | 43.06M | 64.35M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 943.00K | 2.55M | 4.32M | 5.06M | 1.31M | |||
| Accounts Payable | 194.00K | 666.00K | 516.00K | 1.69M | 1.34M | |||
| Total Current Liabilities | 1.14M | 3.22M | 4.84M | 6.75M | 2.65M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 209.00K | 316.00K | 90.00K | 240.00K | |||
| Total Non-Current Liabilities | 0.00 | 209.00K | 316.00K | 90.00K | 240.00K | |||
| TOTAL LIABILITIES | 1.14M | 3.43M | 5.15M | 6.84M | 2.89M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -109.75M | -102.62M | -88.68M | -63.82M | -36.17M | |||
| Additional Paid In Capital | 120.98M | 116.16M | 105.67M | 101.26M | 97.64M | |||
| Common Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Treasury Stock | N/A | N/A | 0.00 | -1.22M | N/A | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 18.78M | 3.60M | 135.46K | 138.66K | 135.95K | |||
| Tangible Book Value per Share | 0.02 | 0.14 | 4.79 | 2.49 | 4.31 | |||
| Total Shareholders' Equity | 11.23M | 13.54M | 17.00M | 36.22M | 61.47M | |||
| TOTAL LIABILITIES AND EQUITY | 12.37M | 16.96M | 22.15M | 43.06M | 64.35M | |||
| Statistics | ||||||||
| Current Ratio | 10.49 | 4.98 | 4.32 | 6.18 | 23.66 | |||
| Return On Assets (ROA) | -81.54% | -82.20% | -109.34% | -64.21% | -19.39% | |||
| Return On Equity (ROE) | -89.80% | -103.01% | -142.50% | -76.34% | -20.30% | |||
All data in USD , ROIC based on taxRate of 0.21